Susumu Kusunoki Selected Research

Ophthalmoplegia (External Ophthalmoplegia)

11/2018	Varied antibody reactivities and clinical relevance in anti-GQ1b antibody-related diseases.
12/2016	Serological study using glycoarray for detecting antibodies to glycolipids and glycolipid complexes in immune-mediated neuropathies.
1/2012	Miller Fisher syndrome associated with influenza A infection.
1/2003	Diagnosis, pathogenesis and treatment of Miller Fisher syndrome and related disorders: clinical significance of antiGQ1b IgG antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susumu Kusunoki Research Topics

Disease

51	Guillain-Barre Syndrome 10/2021 - 01/2003
20	Polyneuropathies (Polyneuropathy) 01/2020 - 11/2009
19	Miller Fisher Syndrome (Fisher Syndrome) 01/2021 - 01/2003
14	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 08/2020 - 11/2009
13	Multiple Sclerosis 08/2021 - 08/2006
12	Infections 11/2020 - 01/2003
11	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 08/2006
10	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 01/2012
8	Parkinson Disease (Parkinson's Disease) 01/2020 - 08/2006
8	Encephalitis (Encephalitis, Rasmussen) 11/2018 - 01/2003
7	Ataxia (Dyssynergia) 08/2020 - 01/2003
7	Respiratory Insufficiency (Respiratory Failure) 11/2018 - 12/2008
6	Disease Progression 09/2021 - 09/2012
6	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2021 - 03/2003
6	Neuromyelitis Optica (Devic's Disease) 04/2018 - 12/2009
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 01/2009
5	Muscle Weakness 04/2020 - 09/2010
4	Ophthalmoplegia (External Ophthalmoplegia) 11/2018 - 01/2003
4	Leukocytosis (Pleocytosis) 10/2018 - 02/2005
4	Deglutition Disorders (Dysphagia) 01/2018 - 09/2013
3	Pain (Aches) 10/2021 - 02/2011
3	Cerebellar Ataxia (Dysmetria) 08/2021 - 10/2005
3	POEMS Syndrome (Syndrome, POEMS) 10/2016 - 05/2013
3	Fever (Fevers) 10/2016 - 08/2006
3	Paraproteinemias (Monoclonal Gammopathy) 10/2016 - 01/2013
3	Tremor (Tremors) 10/2015 - 08/2006
3	Myasthenia Gravis 05/2013 - 07/2005
2	Optic Neuritis (Retrobulbar Neuritis) 12/2021 - 01/2012
2	Nervous System Diseases (Neurological Disorders) 08/2021 - 10/2015
2	Central Nervous System Diseases (CNS Diseases) 01/2021 - 03/2017
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 05/2019 - 09/2011
2	Cytomegalovirus Infections (Inclusion Disease) 06/2018 - 12/2008
2	Multiple System Atrophy 03/2018 - 12/2011
2	Experimental Autoimmune Neuritis 01/2017 - 01/2014
2	Monoclonal Gammopathy of Undetermined Significance 01/2016 - 02/2009
2	Immune System Diseases (Immune Disorders) 12/2015 - 01/2013
2	Diplopia (Double Vision) 07/2014 - 07/2006
2	Polyradiculoneuropathy (Polyradiculoneuritis) 04/2013 - 01/2009
2	Brachial Plexus Neuritis (Parsonage Turner Syndrome) 01/2012 - 09/2011
2	Coma (Comas) 01/2012 - 07/2008
2	Neoplasms (Cancer) 09/2011 - 07/2006
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

53	AntibodiesIBA 01/2021 - 03/2003
28	GangliosidesIBA 01/2021 - 01/2003
25	Intravenous Immunoglobulins (IVIG)FDA Link 10/2021 - 01/2003
24	Immunoglobulin G (IgG)IBA 08/2021 - 01/2003
18	Immunoglobulin M (IgM)IBA 01/2020 - 03/2003
9	AutoantibodiesIBA 08/2021 - 10/2005
9	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2011
9	GlycolipidsIBA 01/2019 - 12/2012
9	AntigensIBA 11/2018 - 10/2004
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2014
5	Pharmaceutical PreparationsIBA 10/2018 - 11/2009
4	Amantadine (Aman)FDA LinkGeneric 09/2021 - 11/2008
4	EnzymesIBA 01/2021 - 10/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 06/2011
4	Myelin-Associated GlycoproteinIBA 02/2015 - 09/2010
4	galactocerebrosideIBA 01/2015 - 12/2012
3	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2021 - 10/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2020 - 02/2005
3	Complement System Proteins (Complement)IBA 01/2020 - 01/2018
3	CytokinesIBA 11/2019 - 11/2014
3	ChemokinesIBA 11/2019 - 11/2014
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2019 - 09/2011
3	Monoclonal AntibodiesIBA 01/2018 - 02/2014
3	Methylprednisolone FDA LinkGeneric 01/2016 - 01/2012
3	ChondroitinIBA 05/2014 - 02/2011
3	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 05/2013 - 07/2005
2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2021 - 01/2020
2	anti-aquaporin 4 autoantibodyIBA 08/2021 - 01/2012
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021 - 04/2013
2	SugarsIBA 01/2021 - 10/2006
2	Therapeutic UsesIBA 01/2020 - 05/2009
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2019 - 11/2014
2	rotigotine FDA Link 09/2019 - 08/2015
2	4-Aminopyridine (4 Aminopyridine)FDA Link 10/2018 - 01/2017
2	Protein Deglycase DJ-1IBA 03/2018 - 04/2014
2	sulfate-3-glucuronyl paraglobosideIBA 01/2018 - 01/2013
2	eculizumab FDA Link 01/2018 - 11/2016
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2015
2	Thalidomide (Thalomid)FDA Link 10/2016 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 01/2015
2	Valosin Containing ProteinIBA 01/2016 - 03/2015
2	G(M1) GangliosideIBA 01/2015 - 12/2010
2	Aquaporin 4IBA 05/2013 - 01/2012
2	SteroidsIBA 12/2012 - 06/2011
2	Prednisolone (Predate)FDA LinkGeneric 01/2010 - 02/2005
2	Edrophonium (Tensilon)FDA LinkGeneric 07/2009 - 07/2006
2	Phospholipids (Phosphatides)FDA LinkGeneric 02/2005 - 03/2003
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	HLA-DRB1*04 antigenIBA 12/2021

Therapy/Procedure

17	Therapeutics 06/2018 - 01/2003
5	Plasma Exchange 01/2019 - 07/2005
4	Plasmapheresis 01/2018 - 01/2003
3	Immunotherapy 11/2019 - 01/2012
3	Aftercare (After-Treatment) 12/2012 - 01/2010
2	Artificial Respiration (Mechanical Ventilation) 04/2020 - 01/2016
2	Transdermal Patch 09/2019 - 08/2015
2	Drug Therapy (Chemotherapy) 02/2014 - 05/2013